Peking University First Hospital
Clinical trials sponsored by Peking University First Hospital, explained in plain language.
-
New hope for patients with Hard-to-Treat urinary tract cancer
Disease control Not yet recruitingThis study tests a new treatment for a rare cancer of the upper urinary tract that has spread into the kidney or nearby lymph nodes. The treatment combines a targeted drug (disitamab vedotin) with radiation therapy, and is compared to standard chemotherapy. About 192 adults who c…
Phase: PHASE2 • Sponsor: Peking University First Hospital • Aim: Disease control
Last updated May 26, 2026 05:06 UTC
-
Could a mother's supplement boost baby health? new trial explores TUDCA for fatty liver
Disease control Not yet recruitingThis study tests whether a supplement called TUDCA, taken by breastfeeding mothers with a fatty liver condition, can improve the health of both mother and baby. Researchers will enroll 80 mother-infant pairs and randomly give the mother either TUDCA or a placebo. The goal is to s…
Phase: PHASE2 • Sponsor: Peking University First Hospital • Aim: Disease control
Last updated May 26, 2026 05:03 UTC
-
New combo therapy aims to keep high-risk prostate cancer at bay after surgery
Disease control Not yet recruitingThis study tests whether adding darolutamide to standard hormone therapy after prostate removal can delay or prevent cancer recurrence in high-risk patients. About 40 men will receive the drug combination for 2 years, with regular PSA tests and scans to monitor outcomes. The goal…
Phase: PHASE2 • Sponsor: Peking University First Hospital • Aim: Disease control
Last updated May 19, 2026 12:00 UTC
-
Kidney-Sparing combo therapy aims to beat cancer without losing the organ
Disease control Not yet recruitingThis study tests a treatment plan for a rare cancer of the kidney and ureter that avoids removing the whole kidney. Patients first have a less invasive surgery to remove the tumor, then receive targeted drugs and radiation. The goal is to see if this approach can prevent the canc…
Sponsor: Peking University First Hospital • Aim: Disease control
Last updated May 15, 2026 11:54 UTC
-
Lab-Grown cells could revolutionize diabetes care
Disease control Not yet recruitingThis trial tests if islet cells made from stem cells can safely help people with diabetes. About 30 adults who have had diabetes for over 5 years and use insulin will receive an infusion of these cells. The goal is to see if the cells can improve blood sugar control and reduce th…
Phase: NA • Sponsor: Peking University First Hospital • Aim: Disease control
Last updated May 15, 2026 11:53 UTC
-
MRI over time could spare men unnecessary prostate biopsies
Diagnosis Not yet recruitingThis study will follow 1000 men with suspected prostate cancer to see if repeated MRI scans can better detect dangerous cancers and reduce the need for biopsies. Participants will have MRI scans over time, and doctors will track how the images change. The goal is to make prostate…
Sponsor: Peking University First Hospital • Aim: Diagnosis
Last updated May 26, 2026 05:06 UTC
-
New scan could spot myeloma spots with precision
Diagnosis Not yet recruitingThis study tests a new type of PET/CT scan that uses a special tracer to find BCMA, a protein on myeloma cells. The goal is to see if this scan can accurately detect active myeloma lesions compared to biopsy. About 300 people with suspected or known multiple myeloma will take par…
Phase: PHASE2, PHASE3 • Sponsor: Peking University First Hospital • Aim: Diagnosis
Last updated May 26, 2026 04:35 UTC
-
New hope for seniors: preventing Post-Surgery brain fog
Prevention Not yet recruitingThis study tests whether giving older patients (65-90) a combination of two medicines (dexmedetomidine and esketamine) plus a gentle brain stimulation technique (tDCS) around the time of surgery can prevent confusion, memory loss, and other thinking problems that often occur afte…
Phase: PHASE4 • Sponsor: Peking University First Hospital • Aim: Prevention
Last updated May 26, 2026 05:04 UTC
-
Brain boost before surgery: new combo aims to stop Post-Op dementia in seniors
Prevention Not yet recruitingThis study looks at whether giving older adults (65-90) a combination of two drugs (dexmedetomidine and esketamine) along with a gentle brain stimulation technique (tDCS) before non-cardiac surgery can prevent long-term memory and thinking problems. About 1160 participants with m…
Phase: PHASE4 • Sponsor: Peking University First Hospital • Aim: Prevention
Last updated May 26, 2026 04:35 UTC
-
Esketamine may shield aging brains from Post-Surgery fog
Symptom relief Not yet recruitingThis study tests whether a low dose of esketamine, a common anesthetic, can prevent confusion and memory problems in older adults after non-cardiac surgery. About 120 patients aged 65-90 will receive one of three esketamine doses or a placebo during and after surgery. The goal is…
Phase: PHASE4 • Sponsor: Peking University First Hospital • Aim: Symptom relief
Last updated May 26, 2026 05:06 UTC
-
Prostate biopsy recovery: could a simple pill prevent urinary trouble?
Symptom relief Not yet recruitingThis study tests whether taking tamsulosin (a drug that relaxes the prostate) before and after a prostate biopsy can prevent serious urination problems. About 1,844 men will either take the drug or receive no preventive medication. The goal is to see if the drug reduces the need …
Phase: PHASE4 • Sponsor: Peking University First Hospital • Aim: Symptom relief
Last updated May 26, 2026 04:37 UTC
-
New drug cocktail aims to cut Post-Surgery pain in half
Symptom relief Not yet recruitingThis study tests whether giving a combination of two drugs, dexmedetomidine and esketamine, before and after spinal surgery can lower the chance of moderate-to-severe pain in the first three days after the operation. About 274 adults aged 40 to 79 having spine surgery will take p…
Phase: PHASE4 • Sponsor: Peking University First Hospital • Aim: Symptom relief
Last updated May 22, 2026 14:02 UTC
-
New combo aims to stop chronic pain after back surgery
Symptom relief Not yet recruitingThis study tests whether giving two drugs together during spinal surgery can lower the chance of long-term pain. About 274 adults aged 40-79 having spine surgery will receive either the drug combo or a placebo. The goal is to see if fewer people have pain 3 to 6 months after surg…
Phase: PHASE4 • Sponsor: Peking University First Hospital • Aim: Symptom relief
Last updated May 22, 2026 14:01 UTC
-
Can a deeper cleanup improve survival in a rare blood disease?
Knowledge-focused Not yet recruitingThis study looks at 50 adults with AL amyloidosis, a rare disease where abnormal proteins damage organs. After initial chemotherapy, some patients still have tiny traces of the disease (called MRD). The study will check if a stem cell transplant can remove those traces and improv…
Phase: NA • Sponsor: Peking University First Hospital • Aim: Knowledge-focused
Last updated May 26, 2026 04:37 UTC
-
Massive study aims to predict deadly clots in liver patients
Knowledge-focused Not yet recruitingThis study will follow about 2,500 adults with liver cirrhosis to learn who develops dangerous blood clots in the liver's main vein. Researchers will review past cases and track new patients for two years to build a prediction tool, measure how clots affect survival, and see if b…
Sponsor: Peking University First Hospital • Aim: Knowledge-focused
Last updated May 26, 2026 04:35 UTC
-
Can anesthesia dosing protect Seniors' brains after surgery?
Knowledge-focused Not yet recruitingThis study looks at how deep anesthesia affects thinking and memory recovery in older adults (65+) after non-heart surgery. Researchers will compare two different anesthesia depths using a fixed drug ratio. The goal is to see if one depth leads to fewer thinking problems after su…
Phase: PHASE4 • Sponsor: Peking University First Hospital • Aim: Knowledge-focused
Last updated May 20, 2026 11:56 UTC